# GO_molecular_function_0095: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/GO_molecular_function_0095.txt)

**Task:** `GO_molecular_function`  
**Author key, unchanged:** **D** — nucleotide binding

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MQAIISTAPGQAALVHDRPLPTIRDGYLLVKTKAVALNPTDWKHIEVTQKPGILFGCDYAGIVEQVGPGVQSGFQPGDRVAGFVHGGNSKEPQDGAFAEYIVAKADLQIHIPEHMSFEEAATLGVGITAVGQGLYQTLSLPFPSPSSIHEDGAEKPANPATQPILIYGASTASGVLGIQFAKLSGFAPLAVCSPDHFDLAERLGAVAVFDYADGEDAVEEIQDYVRGMGQPLLKAWDTISIPSSARFCGDALSSGNGPQYASLLSMTCPRPDVTSTTTMAYTVFGEDWGMGTAHFPASGVDAELGRRWWALVQQLLNEGRIQTHRIIAGEGGLDGVLGGLQQLRDSQVRGGKLVFRV

[Multiple Choices]
A. endopeptidase inhibitor activity
B. 2-oxoglutarate-dependent dioxygenase activity
C. RNA polymerase II general transcription initiation factor activity
D. nucleotide binding
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Molecular Function Prediction, which is to predict the fundamental activity of a protein at the molecular level, as defined by the Gene Ontology (GO) 'Molecular Function' branch. This describes the elemental tasks a protein performs, such as catalysis, transport, or binding to specific molecules. Based on the protein's amino acid sequence, you are to select the option that best describes its primary molecular function.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> A historical UniProt record for the exact sequence annotates nucleotide binding (GO:0000166), with evidence code IEA:UniProtKB-KW. This supports D as a database annotation, though it is not experimental evidence of binding. The same record describes the protein as a trans-enoyl reductase.

Citations as saved: [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> Nucleotide-cofactor use is plausible for an oxidoreductase and makes D more plausible than the unrelated inhibitor, dioxygenase, and transcription-factor choices. But that broad tendency does not establish that this particular protein binds a nucleotide.


**Missing item-specific fact**

> The protein-specific functional annotation or evidence that this trans-enoyl reductase binds a nucleotide cofactor is absent from the input.


**Reason**

> The sequence alone does not provide a sufficiently decisive basis for assigning nucleotide binding; identifying the specific enzyme family and its cofactor or consulting its annotation is needed.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the listed choices, nucleotide binding is supported by the matched-sequence annotation; the supplied evidence does not support another listed option.


### Important caveats

- The nucleotide-binding annotation is computationally assigned (IEA:UniProtKB-KW), not direct experimental evidence.
- The protein’s described enzymatic function, trans-enoyl reductase, is not itself one of the answer choices.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Nucleotide-cofactor use is plausible for an oxidoreductase and makes D more plausible than the unrelated inhibitor, dioxygenase, and transcription-factor choices. But that broad tendency does not establish that this particular protein binds a nucleotide.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific functional annotation or evidence that this trans-enoyl reductase binds a nucleotide cofactor is absent from the input.",
    "reason": "The sequence alone does not provide a sufficiently decisive basis for assigning nucleotide binding; identifying the specific enzyme family and its cofactor or consulting its annotation is needed."
  },
  "case_id": "GO_molecular_function_0095",
  "expected_answer_check": {
    "evidence_ids": [
      "H3",
      "H4"
    ],
    "judgment": "supported",
    "reason": "A historical UniProt record for the exact sequence annotates nucleotide binding (GO:0000166), with evidence code IEA:UniProtKB-KW. This supports D as a database annotation, though it is not experimental evidence of binding. The same record describes the protein as a trans-enoyl reductase."
  },
  "important_caveats": [
    "The nucleotide-binding annotation is computationally assigned (IEA:UniProtKB-KW), not direct experimental evidence.",
    "The protein’s described enzymatic function, trans-enoyl reductase, is not itself one of the answer choices."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the listed choices, nucleotide binding is supported by the matched-sequence annotation; the supplied evidence does not support another listed option."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_molecular_function_0095",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "A historical UniProt record for the exact sequence annotates nucleotide binding (GO:0000166), with evidence code IEA:UniProtKB-KW. This supports D as a database annotation, though it is not experimental evidence of binding. The same record describes the protein as a trans-enoyl reductase.",
    "evidence_ids": ["H3", "H4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "Nucleotide-cofactor use is plausible for an oxidoreductase and makes D more plausible than the unrelated inhibitor, dioxygenase, and transcription-factor choices. But that broad tendency does not establish that this particular protein binds a nucleotide.",
    "missing_item_specific_fact": "The protein-specific functional annotation or evidence that this trans-enoyl reductase binds a nucleotide cofactor is absent from the input.",
    "reason": "The sequence alone does not provide a sufficiently decisive basis for assigning nucleotide binding; identifying the specific enzyme family and its cofactor or consulting its annotation is needed."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the listed choices, nucleotide binding is supported by the matched-sequence annotation; the supplied evidence does not support another listed option."
  },
  "important_caveats": [
    "The nucleotide-binding annotation is computationally assigned (IEA:UniProtKB-KW), not direct experimental evidence.",
    "The protein’s described enzymatic function, trans-enoyl reductase, is not itself one of the answer choices."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry P0DXV9 carries GO:0000166 (nucleotide binding) as an IEA:UniProtKB-KW annotation (evidence H4). This is the only one of the four option terms present in the protein's GO annotations. The other three options (endopeptidase inhibitor, 2-oxoglutarate-dependent dioxygenase, RNA Pol II transcription factor) have no annotation support. However, the annotation is IEA (inferred from electronic keyword), not experimental, and the protein's true primary molecular function is trans-enoyl reductase / oxidoreductase activity (GO:0016651, also IEA:InterPro), which is not among the choices. Nucleotide binding is a secondary cofactor-binding attribute, not the primary catalytic function.

Citations as saved: [H4](#evidence-h4), [H5](#evidence-h5), [C6](#evidence-c6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains motifs consistent with an NAD(P)H-binding reductase domain (e.g., GxGxxG-like patterns such as 'GEWGMG' and 'GASTASG', and overall domain architecture typical of enoyl-reductase / short-chain dehydrogenase domains found in PKS clusters). A reductase binds a nucleotide cofactor (NAD(P)H), making 'nucleotide binding' the only option consistent with a reductase. Options A (endopeptidase inhibitor), B (2-oxoglutarate-dependent dioxygenase, requiring a His/His/Asp triad and specific substrate-binding pocket), and C (RNA Pol II general transcription factor, requiring protein-protein interaction domains like TFIIB/TFIID motifs) are all inconsistent with the observed sequence features. This elimination-based reasoning provides meaningful grounds to select D.


**Missing item-specific fact**

> None strictly required; however, the question's framing as 'primary molecular function' is misleading because the true primary function is oxidoreductase (enoyl reductase) activity, not nucleotide binding. The answer relies on the fact that oxidoreductase is not among the options, forcing selection of the broad secondary annotation.


**Reason**

> General biological knowledge (reductases bind NAD(P)H; dioxygenases require 2-oxoglutarate-binding motifs; transcription factors have distinct domain architectures) provides a concrete path to eliminate A, B, C and select D. The reasoning is somewhat indirect because 'nucleotide binding' is a broad secondary annotation rather than the true primary catalytic function, but the elimination logic is defensible from sequence features alone.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A, B, and C are clearly inconsistent with any reductase-like protein. Among the four choices, only D has any annotation support and any biological plausibility. The ambiguity lies not between the options but in the question stem's use of 'primary molecular function' when the true primary function (oxidoreductase/enoyl reductase) is not offered, making D the 'best available' rather than the 'primary' function.


### Important caveats

- The GO:0000166 annotation is IEA:UniProtKB-KW (keyword-inferred), not experimentally validated. It reflects a broad cofactor-binding attribute, not the protein's defining catalytic activity.
- The protein's primary molecular function is trans-enoyl reductase (oxidoreductase, GO:0016651, IEA:InterPro). The question stem asks for 'primary molecular function' but the correct answer is a secondary binding annotation, creating a mismatch between the question framing and the answer.
- The sequence match to P0DXV9 is confirmed (SHA-256 match, 357 aa, sequence version 1). The entry was first released 2025-02-05.
- All evidence codes for the relevant GO annotations are IEA (computational inference), not experimental (no IDA, IMP, IPI, etc.).

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains motifs consistent with an NAD(P)H-binding reductase domain (e.g., GxGxxG-like patterns such as 'GEWGMG' and 'GASTASG', and overall domain architecture typical of enoyl-reductase / short-chain dehydrogenase domains found in PKS clusters). A reductase binds a nucleotide cofactor (NAD(P)H), making 'nucleotide binding' the only option consistent with a reductase. Options A (endopeptidase inhibitor), B (2-oxoglutarate-dependent dioxygenase, requiring a His/His/Asp triad and specific substrate-binding pocket), and C (RNA Pol II general transcription factor, requiring protein-protein interaction domains like TFIIB/TFIID motifs) are all inconsistent with the observed sequence features. This elimination-based reasoning provides meaningful grounds to select D.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None strictly required; however, the question's framing as 'primary molecular function' is misleading because the true primary function is oxidoreductase (enoyl reductase) activity, not nucleotide binding. The answer relies on the fact that oxidoreductase is not among the options, forcing selection of the broad secondary annotation.",
    "reason": "General biological knowledge (reductases bind NAD(P)H; dioxygenases require 2-oxoglutarate-binding motifs; transcription factors have distinct domain architectures) provides a concrete path to eliminate A, B, C and select D. The reasoning is somewhat indirect because 'nucleotide binding' is a broad secondary annotation rather than the true primary catalytic function, but the elimination logic is defensible from sequence features alone."
  },
  "case_id": "GO_molecular_function_0095",
  "expected_answer_check": {
    "evidence_ids": [
      "H4",
      "H5",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry P0DXV9 carries GO:0000166 (nucleotide binding) as an IEA:UniProtKB-KW annotation (evidence H4). This is the only one of the four option terms present in the protein's GO annotations. The other three options (endopeptidase inhibitor, 2-oxoglutarate-dependent dioxygenase, RNA Pol II transcription factor) have no annotation support. However, the annotation is IEA (inferred from electronic keyword), not experimental, and the protein's true primary molecular function is trans-enoyl reductase / oxidoreductase activity (GO:0016651, also IEA:InterPro), which is not among the choices. Nucleotide binding is a secondary cofactor-binding attribute, not the primary catalytic function."
  },
  "important_caveats": [
    "The GO:0000166 annotation is IEA:UniProtKB-KW (keyword-inferred), not experimentally validated. It reflects a broad cofactor-binding attribute, not the protein's defining catalytic activity.",
    "The protein's primary molecular function is trans-enoyl reductase (oxidoreductase, GO:0016651, IEA:InterPro). The question stem asks for 'primary molecular function' but the correct answer is a secondary binding annotation, creating a mismatch between the question framing and the answer.",
    "The sequence match to P0DXV9 is confirmed (SHA-256 match, 357 aa, sequence version 1). The entry was first released 2025-02-05.",
    "All evidence codes for the relevant GO annotations are IEA (computational inference), not experimental (no IDA, IMP, IPI, etc.)."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, B, and C are clearly inconsistent with any reductase-like protein. Among the four choices, only D has any annotation support and any biological plausibility. The ambiguity lies not between the options but in the question stem's use of 'primary molecular function' when the true primary function (oxidoreductase/enoyl reductase) is not offered, making D the 'best available' rather than the 'primary' function."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_molecular_function_0095",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry P0DXV9 carries GO:0000166 (nucleotide binding) as an IEA:UniProtKB-KW annotation (evidence H4). This is the only one of the four option terms present in the protein's GO annotations. The other three options (endopeptidase inhibitor, 2-oxoglutarate-dependent dioxygenase, RNA Pol II transcription factor) have no annotation support. However, the annotation is IEA (inferred from electronic keyword), not experimental, and the protein's true primary molecular function is trans-enoyl reductase / oxidoreductase activity (GO:0016651, also IEA:InterPro), which is not among the choices. Nucleotide binding is a secondary cofactor-binding attribute, not the primary catalytic function.",
    "evidence_ids": ["H4", "H5", "C6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains motifs consistent with an NAD(P)H-binding reductase domain (e.g., GxGxxG-like patterns such as 'GEWGMG' and 'GASTASG', and overall domain architecture typical of enoyl-reductase / short-chain dehydrogenase domains found in PKS clusters). A reductase binds a nucleotide cofactor (NAD(P)H), making 'nucleotide binding' the only option consistent with a reductase. Options A (endopeptidase inhibitor), B (2-oxoglutarate-dependent dioxygenase, requiring a His/His/Asp triad and specific substrate-binding pocket), and C (RNA Pol II general transcription factor, requiring protein-protein interaction domains like TFIIB/TFIID motifs) are all inconsistent with the observed sequence features. This elimination-based reasoning provides meaningful grounds to select D.",
    "missing_item_specific_fact": "None strictly required; however, the question's framing as 'primary molecular function' is misleading because the true primary function is oxidoreductase (enoyl reductase) activity, not nucleotide binding. The answer relies on the fact that oxidoreductase is not among the options, forcing selection of the broad secondary annotation.",
    "reason": "General biological knowledge (reductases bind NAD(P)H; dioxygenases require 2-oxoglutarate-binding motifs; transcription factors have distinct domain architectures) provides a concrete path to eliminate A, B, C and select D. The reasoning is somewhat indirect because 'nucleotide binding' is a broad secondary annotation rather than the true primary catalytic function, but the elimination logic is defensible from sequence features alone."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, B, and C are clearly inconsistent with any reductase-like protein. Among the four choices, only D has any annotation support and any biological plausibility. The ambiguity lies not between the options but in the question stem's use of 'primary molecular function' when the true primary function (oxidoreductase/enoyl reductase) is not offered, making D the 'best available' rather than the 'primary' function."
  },
  "important_caveats": [
    "The GO:0000166 annotation is IEA:UniProtKB-KW (keyword-inferred), not experimentally validated. It reflects a broad cofactor-binding attribute, not the protein's defining catalytic activity.",
    "The protein's primary molecular function is trans-enoyl reductase (oxidoreductase, GO:0016651, IEA:InterPro). The question stem asks for 'primary molecular function' but the correct answer is a secondary binding annotation, creating a mismatch between the question framing and the answer.",
    "The sequence match to P0DXV9 is confirmed (SHA-256 match, 357 aa, sequence version 1). The entry was first released 2025-02-05.",
    "All evidence codes for the relevant GO annotations are IEA (computational inference), not experimental (no IDA, IMP, IPI, etc.)."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The matched historical UniProt record assigns nucleotide binding (GO:0000166), but the evidence is IEA:UniProtKB-KW, not direct experimental demonstration of binding. The record also describes the protein as a trans-enoyl reductase, consistent with nucleotide-cofactor use.

Citations as saved: [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence is compatible with an enzyme-like oxidoreductase with cofactor-binding features. Transferable knowledge about enoyl reductases and related reductases supports use of NAD(P)H as a hydride donor; NAD(P)H contains a nucleotide moiety, making nucleotide binding the meaningful offered choice. This is a family-level inference, not proof of the exact annotation or cofactor specificity.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The reductase/cofactor-binding inference distinguishes D from the unrelated inhibitor, 2-oxoglutarate-dependent dioxygenase, and transcription-initiation-factor choices without needing the target's database record.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the supplied alternatives, nucleotide binding is the only one meaningfully consistent with the reductase/cofactor-binding inference.


### Important caveats

- The supplied annotation is computational/keyword-based rather than experimental evidence for nucleotide binding.
- The exact molecular function of the enzyme may be more specific than the broad offered term.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is compatible with an enzyme-like oxidoreductase with cofactor-binding features. Transferable knowledge about enoyl reductases and related reductases supports use of NAD(P)H as a hydride donor; NAD(P)H contains a nucleotide moiety, making nucleotide binding the meaningful offered choice. This is a family-level inference, not proof of the exact annotation or cofactor specificity.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The reductase/cofactor-binding inference distinguishes D from the unrelated inhibitor, 2-oxoglutarate-dependent dioxygenase, and transcription-initiation-factor choices without needing the target's database record."
  },
  "case_id": "GO_molecular_function_0095",
  "expected_answer_check": {
    "evidence_ids": [
      "H3",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The matched historical UniProt record assigns nucleotide binding (GO:0000166), but the evidence is IEA:UniProtKB-KW, not direct experimental demonstration of binding. The record also describes the protein as a trans-enoyl reductase, consistent with nucleotide-cofactor use."
  },
  "important_caveats": [
    "The supplied annotation is computational/keyword-based rather than experimental evidence for nucleotide binding.",
    "The exact molecular function of the enzyme may be more specific than the broad offered term."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the supplied alternatives, nucleotide binding is the only one meaningfully consistent with the reductase/cofactor-binding inference."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_molecular_function_0095",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The matched historical UniProt record assigns nucleotide binding (GO:0000166), but the evidence is IEA:UniProtKB-KW, not direct experimental demonstration of binding. The record also describes the protein as a trans-enoyl reductase, consistent with nucleotide-cofactor use.",
    "evidence_ids": ["H3", "H4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence is compatible with an enzyme-like oxidoreductase with cofactor-binding features. Transferable knowledge about enoyl reductases and related reductases supports use of NAD(P)H as a hydride donor; NAD(P)H contains a nucleotide moiety, making nucleotide binding the meaningful offered choice. This is a family-level inference, not proof of the exact annotation or cofactor specificity.",
    "missing_item_specific_fact": "",
    "reason": "The reductase/cofactor-binding inference distinguishes D from the unrelated inhibitor, 2-oxoglutarate-dependent dioxygenase, and transcription-initiation-factor choices without needing the target's database record."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the supplied alternatives, nucleotide binding is the only one meaningfully consistent with the reductase/cofactor-binding inference."
  },
  "important_caveats": [
    "The supplied annotation is computational/keyword-based rather than experimental evidence for nucleotide binding.",
    "The exact molecular function of the enzyme may be more specific than the broad offered term."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry P0DXV9 annotates GO:0000166 (nucleotide binding) with evidence code IEA:UniProtKB-KW (keyword-based inference). The protein is a trans-enoyl reductase (EC 1.-.-.-) that uses NAD(P)H as a cofactor in the restricticin biosynthesis pathway. NAD(P)H is a nucleotide, so the 'nucleotide binding' annotation is biochemically valid. The annotation is keyword-inferred (IEA), not experimentally verified, but the underlying enzymatic mechanism (NADPH-dependent reduction) supports the claim.

Citations as saved: [H4](#evidence-h4), [H5](#evidence-h5), [C6](#evidence-c6), [C5](#evidence-c5).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence (~357 aa) contains motifs consistent with a Rossmann-fold nucleotide-binding domain: patterns like 'GQGL' (~pos 120) and 'GASTASG' (~pos 155) resemble the GxGxxG dinucleotide-binding signature. Trans-enoyl reductases in modular polyketide synthase (PKS) systems are a well-characterized family of NADPH-dependent oxidoreductases; recognizing the sequence as belonging to this reductase superfamily (supported by length, composition, and the putative Rossmann motif) implies NAD(P)H binding, and NAD(P)H is a nucleotide. The other options can be eliminated: (A) endopeptidase inhibitors require a reactive-center loop or specific inhibitor scaffolds (serpin, cystatin, etc.) absent here; (B) 2-oxoglutarate-dependent dioxygenases require a characteristic HxD/E…H facial triad and specific active-site architecture not evident; (C) RNA Pol II general transcription factors (TFIIB, TFIID, TFIIH, etc.) have well-known domains and lengths inconsistent with this sequence. Thus, family-level recognition of a reductase with nucleotide-binding motifs meaningfully distinguishes option D.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A knowledgeable model can use sequence motif recognition (Rossmann-like GxGxxG patterns), family knowledge of NADPH-dependent trans-enoyl reductases in PKS systems, and elimination of structurally incompatible alternatives to select 'nucleotide binding' without memorizing this specific protein's database entry.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> While 'nucleotide binding' is a very broad GO term, among the four offered choices only D is consistent with an NAD(P)H-dependent reductase. The other three options describe fundamentally different protein classes with distinct structural requirements not present in the sequence. No other option is defensible given the sequence features.


### Important caveats

- The GO:0000166 annotation is IEA:UniProtKB-KW (keyword-based), the lowest-confidence evidence tier; the more specific GO:0016651 (oxidoreductase activity, acting on NAD(P)H) is also IEA:InterPro. Neither is experimentally validated for this exact protein.
- 'Nucleotide binding' is an extremely broad molecular function; the protein's primary catalytic activity is trans-enoyl reduction, but that specific term was not offered as a choice.
- The Rossmann-fold motif identification from raw sequence is suggestive but not definitive without structural confirmation; the argument relies on probabilistic pattern recognition and family-level knowledge.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence (~357 aa) contains motifs consistent with a Rossmann-fold nucleotide-binding domain: patterns like 'GQGL' (~pos 120) and 'GASTASG' (~pos 155) resemble the GxGxxG dinucleotide-binding signature. Trans-enoyl reductases in modular polyketide synthase (PKS) systems are a well-characterized family of NADPH-dependent oxidoreductases; recognizing the sequence as belonging to this reductase superfamily (supported by length, composition, and the putative Rossmann motif) implies NAD(P)H binding, and NAD(P)H is a nucleotide. The other options can be eliminated: (A) endopeptidase inhibitors require a reactive-center loop or specific inhibitor scaffolds (serpin, cystatin, etc.) absent here; (B) 2-oxoglutarate-dependent dioxygenases require a characteristic HxD/E…H facial triad and specific active-site architecture not evident; (C) RNA Pol II general transcription factors (TFIIB, TFIID, TFIIH, etc.) have well-known domains and lengths inconsistent with this sequence. Thus, family-level recognition of a reductase with nucleotide-binding motifs meaningfully distinguishes option D.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can use sequence motif recognition (Rossmann-like GxGxxG patterns), family knowledge of NADPH-dependent trans-enoyl reductases in PKS systems, and elimination of structurally incompatible alternatives to select 'nucleotide binding' without memorizing this specific protein's database entry."
  },
  "case_id": "GO_molecular_function_0095",
  "expected_answer_check": {
    "evidence_ids": [
      "H4",
      "H5",
      "C6",
      "C5"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry P0DXV9 annotates GO:0000166 (nucleotide binding) with evidence code IEA:UniProtKB-KW (keyword-based inference). The protein is a trans-enoyl reductase (EC 1.-.-.-) that uses NAD(P)H as a cofactor in the restricticin biosynthesis pathway. NAD(P)H is a nucleotide, so the 'nucleotide binding' annotation is biochemically valid. The annotation is keyword-inferred (IEA), not experimentally verified, but the underlying enzymatic mechanism (NADPH-dependent reduction) supports the claim."
  },
  "important_caveats": [
    "The GO:0000166 annotation is IEA:UniProtKB-KW (keyword-based), the lowest-confidence evidence tier; the more specific GO:0016651 (oxidoreductase activity, acting on NAD(P)H) is also IEA:InterPro. Neither is experimentally validated for this exact protein.",
    "'Nucleotide binding' is an extremely broad molecular function; the protein's primary catalytic activity is trans-enoyl reduction, but that specific term was not offered as a choice.",
    "The Rossmann-fold motif identification from raw sequence is suggestive but not definitive without structural confirmation; the argument relies on probabilistic pattern recognition and family-level knowledge."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "While 'nucleotide binding' is a very broad GO term, among the four offered choices only D is consistent with an NAD(P)H-dependent reductase. The other three options describe fundamentally different protein classes with distinct structural requirements not present in the sequence. No other option is defensible given the sequence features."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_molecular_function_0095",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry P0DXV9 annotates GO:0000166 (nucleotide binding) with evidence code IEA:UniProtKB-KW (keyword-based inference). The protein is a trans-enoyl reductase (EC 1.-.-.-) that uses NAD(P)H as a cofactor in the restricticin biosynthesis pathway. NAD(P)H is a nucleotide, so the 'nucleotide binding' annotation is biochemically valid. The annotation is keyword-inferred (IEA), not experimentally verified, but the underlying enzymatic mechanism (NADPH-dependent reduction) supports the claim.",
    "evidence_ids": ["H4", "H5", "C6", "C5"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence (~357 aa) contains motifs consistent with a Rossmann-fold nucleotide-binding domain: patterns like 'GQGL' (~pos 120) and 'GASTASG' (~pos 155) resemble the GxGxxG dinucleotide-binding signature. Trans-enoyl reductases in modular polyketide synthase (PKS) systems are a well-characterized family of NADPH-dependent oxidoreductases; recognizing the sequence as belonging to this reductase superfamily (supported by length, composition, and the putative Rossmann motif) implies NAD(P)H binding, and NAD(P)H is a nucleotide. The other options can be eliminated: (A) endopeptidase inhibitors require a reactive-center loop or specific inhibitor scaffolds (serpin, cystatin, etc.) absent here; (B) 2-oxoglutarate-dependent dioxygenases require a characteristic HxD/E…H facial triad and specific active-site architecture not evident; (C) RNA Pol II general transcription factors (TFIIB, TFIID, TFIIH, etc.) have well-known domains and lengths inconsistent with this sequence. Thus, family-level recognition of a reductase with nucleotide-binding motifs meaningfully distinguishes option D.",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can use sequence motif recognition (Rossmann-like GxGxxG patterns), family knowledge of NADPH-dependent trans-enoyl reductases in PKS systems, and elimination of structurally incompatible alternatives to select 'nucleotide binding' without memorizing this specific protein's database entry."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "While 'nucleotide binding' is a very broad GO term, among the four offered choices only D is consistent with an NAD(P)H-dependent reductase. The other three options describe fundamentally different protein classes with distinct structural requirements not present in the sequence. No other option is defensible given the sequence features."
  },
  "important_caveats": [
    "The GO:0000166 annotation is IEA:UniProtKB-KW (keyword-based), the lowest-confidence evidence tier; the more specific GO:0016651 (oxidoreductase activity, acting on NAD(P)H) is also IEA:InterPro. Neither is experimentally validated for this exact protein.",
    "'Nucleotide binding' is an extremely broad molecular function; the protein's primary catalytic activity is trans-enoyl reduction, but that specific term was not offered as a choice.",
    "The Rossmann-fold motif identification from raw sequence is suggestive but not definitive without structural confirmation; the argument relies on probabilistic pattern recognition and family-level knowledge."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "P0DXV9",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "9469ba1064baba46c4b8a0d5b1139bfae6c739cf6631aa8deeb889bb25b40b21",
  "benchmark_sequence_length": 357,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 6,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2025-02-05",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "current_source_sequence_sha256": "9469ba1064baba46c4b8a0d5b1139bfae6c739cf6631aa8deeb889bb25b40b21",
  "current_source_sequence_length": 357,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 4,
  "selected_historical_version": {
    "accession": "P0DXV9",
    "database": "Swiss-Prot",
    "entryVersion": 4,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "RESD_ASPSL",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "50948681abaa65d91ada1f1b7abe16915d33f113843973d2c3d87f65be73d5b0",
  "selected_historical_source_sequence_sha256": "9469ba1064baba46c4b8a0d5b1139bfae6c739cf6631aa8deeb889bb25b40b21",
  "selected_historical_source_sequence_length": 357,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 4,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"P0DXV9\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":6,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2025-02-05\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Eurotiomycetes\",\"Eurotiomycetidae\",\"Eurotiales\",\"Aspergillaceae\",\"Aspergillus\",\"Circumdati\"],\"scientificName\":\"Aspergillus sclerotiorum\",\"taxonId\":138282}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Restricticin biosynthesis cluster protein D\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"1.-.-.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Trans-enoyl reductase resD\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "json_pointer": "/comments/0",
  "excerpt": "{\"commentType\":\"FUNCTION\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000250\",\"id\":\"A0A0L1JEX1\",\"source\":\"UniProtKB\"},{\"evidenceCode\":\"ECO:0000269\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Trans-enoyl reductase; part of the gene cluster that mediates the biosynthesis of the tetrahydropyranyl antifungal agent restricticin that acts as an inhibitor of CYP51 and blocks the ergosterol biosynthesis (PubMed:39105744). The highly reducing polyketide synthase resH, the short chain dehydrogenase resG, the cyclase resF, the FAD-dependent monooxygenase resA and the enoylreductase resD are required to generate the first stable intermediate desmethylrestrictinol. ResH with resD biosynthesize the first polyketide chain intermediate that is reduced by resG, followed by epoxidation by resA before 6-endo cyclization via epoxide opening by resF leads to desmethylrestrictinol. The methyltransferase resE then catalyzes the C4 O-methylation of desmethylrestrictinol to produce restrictinol, and the nonribosomal peptide synthetase resC catalyzes the C3 esterification of restrictinol with glycine that leads to restricticin (By similarity)\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "json_pointer": "/uniProtKBCrossReferences/2",
  "excerpt": "{\"database\":\"GO\",\"id\":\"GO:0016651\",\"properties\":[{\"key\":\"GoTerm\",\"value\":\"F:oxidoreductase activity, acting on NAD(P)H\"},{\"key\":\"GoEvidenceType\",\"value\":\"IEA:InterPro\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C7",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Lu Y.\",\"Li Y.\",\"Dou M.\",\"Liu D.\",\"Lin W.\",\"Fan A.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"39105744\"},{\"database\":\"DOI\",\"id\":\"10.1021/acs.jafc.4c04244\"}],\"citationType\":\"journal article\",\"firstPage\":\"18520\",\"id\":\"39105744\",\"journal\":\"J. Agric. Food Chem.\",\"lastPage\":\"18527\",\"publicationDate\":\"2024\",\"title\":\"Discovery of a hybrid molecule with phytotoxic activity by genome mining, heterologous expression, and OSMAC strategy.\",\"volume\":\"72\"},\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4",
  "source_sha256": "50948681abaa65d91ada1f1b7abe16915d33f113843973d2c3d87f65be73d5b0",
  "retrieved_utc": "2026-11-02T04:29:51.221408+00:00",
  "source_locator": "lines 1-14",
  "excerpt": "ID   RESD_ASPSL              Reviewed;         357 AA.\nAC   P0DXV9;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   05-FEB-2025, sequence version 1.\nDT   28-JAN-2026, entry version 4.\nDE   RecName: Full=Trans-enoyl reductase resD {ECO:0000303|PubMed:39105744};\nDE            EC=1.-.-.- {ECO:0000305|PubMed:39105744};\nDE   AltName: Full=Restricticin biosynthesis cluster protein D {ECO:0000303|PubMed:39105744};\nGN   Name=resD {ECO:0000303|PubMed:39105744};\nOS   Aspergillus sclerotiorum.\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;\nOC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;\nOC   Aspergillus subgen. Circumdati.\nOX   NCBI_TaxID=138282;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 4,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4",
  "source_sha256": "50948681abaa65d91ada1f1b7abe16915d33f113843973d2c3d87f65be73d5b0",
  "retrieved_utc": "2026-11-02T04:29:51.221408+00:00",
  "source_locator": "lines 15-21",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.\nRX   PubMed=39105744; DOI=10.1021/acs.jafc.4c04244;\nRA   Lu Y., Li Y., Dou M., Liu D., Lin W., Fan A.;\nRT   \"Discovery of a hybrid molecule with phytotoxic activity by genome mining,\nRT   heterologous expression, and OSMAC strategy.\";\nRL   J. Agric. Food Chem. 72:18520-18527(2024).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 4,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4",
  "source_sha256": "50948681abaa65d91ada1f1b7abe16915d33f113843973d2c3d87f65be73d5b0",
  "retrieved_utc": "2026-11-02T04:29:51.221408+00:00",
  "source_locator": "lines 22-36",
  "excerpt": "CC   -!- FUNCTION: Trans-enoyl reductase; part of the gene cluster that mediates\nCC       the biosynthesis of the tetrahydropyranyl antifungal agent restricticin\nCC       that acts as an inhibitor of CYP51 and blocks the ergosterol\nCC       biosynthesis (PubMed:39105744). The highly reducing polyketide synthase\nCC       resH, the short chain dehydrogenase resG, the cyclase resF, the FAD-\nCC       dependent monooxygenase resA and the enoylreductase resD are required\nCC       to generate the first stable intermediate desmethylrestrictinol. ResH\nCC       with resD biosynthesize the first polyketide chain intermediate that is\nCC       reduced by resG, followed by epoxidation by resA before 6-endo\nCC       cyclization via epoxide opening by resF leads to desmethylrestrictinol.\nCC       The methyltransferase resE then catalyzes the C4 O-methylation of\nCC       desmethylrestrictinol to produce restrictinol, and the nonribosomal\nCC       peptide synthetase resC catalyzes the C3 esterification of restrictinol\nCC       with glycine that leads to restricticin (By similarity).\nCC       {ECO:0000250|UniProtKB:A0A0L1JEX1, ECO:0000269|PubMed:39105744}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 4,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4)

```json
{
  "evidence_id": "H4",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4",
  "source_sha256": "50948681abaa65d91ada1f1b7abe16915d33f113843973d2c3d87f65be73d5b0",
  "retrieved_utc": "2026-11-02T04:29:51.221408+00:00",
  "source_locator": "lines 45-45",
  "excerpt": "DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 4,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4)

```json
{
  "evidence_id": "H5",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4",
  "source_sha256": "50948681abaa65d91ada1f1b7abe16915d33f113843973d2c3d87f65be73d5b0",
  "retrieved_utc": "2026-11-02T04:29:51.221408+00:00",
  "source_locator": "lines 46-46",
  "excerpt": "DR   GO; GO:0016651; F:oxidoreductase activity, acting on NAD(P)H; IEA:InterPro.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 4,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence GO1

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO1",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 1671-1682",
  "excerpt": "[Term]\nid: GO:0000166\nname: nucleotide binding\nnamespace: molecular_function\ndef: \"Binding to a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.\" [GOC:mah, ISBN:0198547684]\nsubset: goslim_chembl\nsubset: goslim_metagenomics\nsubset: goslim_pir\nsubset: goslim_plant\nis_a: GO:1901265 ! nucleoside phosphate binding\nis_a: GO:1901363 ! heterocyclic compound binding\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0000166"
}
```

### Evidence GO2

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO2",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 51565-51575",
  "excerpt": "[Term]\nid: GO:0004866\nname: endopeptidase inhibitor activity\nnamespace: molecular_function\ndef: \"Binds to and stops, prevents or reduces the activity of an endopeptidase.\" [GOC:jl]\nsynonym: \"alpha-2 macroglobulin\" RELATED []\nsynonym: \"endoproteinase inhibitor\" NARROW []\nsynonym: \"proteinase inhibitor\" NARROW []\nis_a: GO:0030414 ! peptidase inhibitor activity\nis_a: GO:0061135 ! endopeptidase regulator activity\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0004866"
}
```

### Evidence GO3

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO3",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 125030-125048",
  "excerpt": "[Term]\nid: GO:0016251\nname: RNA polymerase II general transcription initiation factor activity\nnamespace: molecular_function\nalt_id: GO:0000983\nalt_id: GO:0001075\nalt_id: GO:0003703\ndef: \"A general transcription initiation factor activity that contributes to transcription start site selection and transcription initiation of genes transcribed by RNA polymerase II. The general transcription factors for RNA polymerase II include TFIIB, TFIID, TFIIE, TFIIF, TFIIH and TATA-binding protein (TBP). In most species, RNA polymerase II transcribes all messenger RNAs (mRNAs), most untranslated regulatory RNAs, the majority of the snoRNAs, four of the five snRNAs (U1, U2, U4, and U5), and other small noncoding RNAs. For some small RNAs there is variability between species as to whether it is transcribed by RNA polymerase II or RNA polymerase III. However there are also rare exceptions, such as Trypanosoma brucei, where RNA polymerase I transcribes certain mRNAs in addition to its normal role in rRNA transcription.\" [GOC:txnOH-2018, PMID:10384286, PMID:10747032, PMID:23442138, PMID:25693126]\ncomment: General transcription factors assemble with the RNA polymerase at promoter DNA to form the pre-initiation complex (PIC), bind to and open promoter DNA, initiate RNA synthesis and stimulate the escape of the polymerase from the promoter. Not all subunits of the general transcription factor are necessarily present in all promoters to initiate transcription. The distinction between general transcription factors and DNA-binding transcription factors is that the latter modulate the selection of which genes are expressed under specific conditions, while general transcription factors belong to the constitutive machinery required for transcription to occur.\nsynonym: \"basal RNA polymerase II transcription factor activity\" EXACT []\nsynonym: \"general RNA polymerase II transcription factor activity\" EXACT []\nsynonym: \"GTF2 activity\" EXACT []\nsynonym: \"RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity\" RELATED []\nsynonym: \"RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity involved in preinitiation complex assembly\" RELATED []\nsynonym: \"sequence-specific core promoter binding RNA polymerase II transcription factor activity involved in preinitiation complex assembly\" RELATED []\nsynonym: \"transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly\" RELATED []\nsynonym: \"transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding\" RELATED []\nis_a: GO:0140223 ! general transcription initiation factor activity\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0016251"
}
```

### Evidence GO4

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO4",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 129228-129242",
  "excerpt": "[Term]\nid: GO:0016706\nname: 2-oxoglutarate-dependent dioxygenase activity\nnamespace: molecular_function\nalt_id: GO:0010302\ndef: \"Catalysis of the reaction: A + 2-oxoglutarate + O2 = B + succinate + CO2. This is an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from 2-oxoglutarate and one other donor, and one atom of oxygen is incorporated into each donor.\" [GOC:mah]\nsynonym: \"2-oxoglutarate dioxygenase activity\" EXACT []\nsynonym: \"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors\" EXACT []\nxref: EC:1.14.11.-\nxref: Reactome:R-HSA-1234164 \"Cytosolic HIF1AN (FIH1) hydroxylates asparagine residues of Hypoxia-inducible Factor Alpha (HIF1A,HIF2A)\"\nxref: Reactome:R-HSA-6783455 \"TYW5 hydroxylates yW-72 yielding OHyW-72 at nucleotide 37 of tRNA(Phe)\"\nis_a: GO:0016705 ! oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen\nis_a: GO:0051213 ! dioxygenase activity\nproperty_value: skos:exactMatch EC:1.14.11.-\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0016706"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_molecular_function.json), zero-based source row 95. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
